Follow the people · Insider
Helen Sabzevari
Helen Sabzevari files insider transactions with the SEC as a president and ceo of Precigen (PGEN). We hold 2 disclosed purchases and sales filed since 8 January 2018, 1 of them in the last 90 days.
- Files forPGEN
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure25 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 23 March 2020 — 23 August 2026President and CEO · Precigen (PGEN)89 Form 4 lines · source: SEC Form 4
- Filed 24 June 2021 — 3 April 2024Director · Kinnate Biopharma (KNTE)6 Form 4 lines · source: SEC Form 4
- Filed 2 January 2018 — 6 January 2020President and CEO · Intrexon (XON)34 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 20,833 shares of PrecigenSEC Form 425 August 2026Common Stock · traded 23 August 2026 · filed 25 August 2026
- had shares withheld for tax on 10,184 shares of PrecigenSEC Form 425 August 2026Common Stock · traded 23 August 2026 · filed 25 August 2026
- exercised options over 20,833 shares of Precigen (a derivative holding)SEC Form 425 August 2026Restricted Stock Units · traded 23 August 2026 · filed 25 August 2026
- exercised options over 346,836 shares of PrecigenSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 346,836 shares of PrecigenSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- exercised options over 346,836 shares of Precigen (a derivative holding)SEC Form 41 July 2026Option to Purchase Common Stock (Right to Buy) · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 119,250 shares of PrecigenSEC Form 41 June 2026Common Stock · traded 28 May 2026 · filed 1 June 2026
- exercised options over 250,000 shares of PrecigenSEC Form 427 May 2026Common Stock · traded 23 May 2026 · filed 27 May 2026
- exercised options over 250,000 shares of Precigen (a derivative holding)SEC Form 427 May 2026Restricted Stock Units · traded 23 May 2026 · filed 27 May 2026
- was granted 1,366,000 shares of Precigen (a derivative holding)SEC Form 422 April 2026Option to Purchase Common Stock (Right to Buy) · traded 20 April 2026 · filed 22 April 2026
- was granted 410,000 shares of Precigen (a derivative holding)SEC Form 422 April 2026Restricted Stock Units · traded 20 April 2026 · filed 22 April 2026
- exercised options over 321,100 shares of PrecigenSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- was granted 321,100 shares of Precigen (a derivative holding)SEC Form 420 March 2026Restricted Stock Units · traded 18 March 2026 · filed 20 March 2026
- exercised options over 321,100 shares of Precigen (a derivative holding)SEC Form 420 March 2026Restricted Stock Units · traded 18 March 2026 · filed 20 March 2026
- was granted 321,100 shares of Precigen (a derivative holding)SEC Form 420 March 2026Restricted Stock Units · traded 18 March 2026 · filed 20 March 2026
- exercised options over 321,100 shares of Precigen (a derivative holding)SEC Form 420 March 2026Restricted Stock Units · traded 18 March 2026 · filed 20 March 2026
- exercised options over 321,100 shares of PrecigenSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- was granted 825,000 shares of Precigen (a derivative holding)SEC Form 416 September 2025Performance Stock Units · traded 12 September 2025 · filed 16 September 2025
- was granted 500,000 shares of Precigen (a derivative holding)SEC Form 427 June 2025Restricted Stock Units · traded 26 June 2025 · filed 27 June 2025
- was granted 1,000,000 shares of Precigen (a derivative holding)SEC Form 427 May 2025Option to Purchase Common Stock (Right to Buy) · traded 23 May 2025 · filed 27 May 2025
- exercised options over 1,079,137 shares of Precigen (a derivative holding)SEC Form 416 May 2025Restricted Stock Units · traded 16 May 2025 · filed 16 May 2025
- exercised options over 1,079,137 shares of PrecigenSEC Form 416 May 2025Common Stock · traded 16 May 2025 · filed 16 May 2025
- had shares withheld for tax on 521,224 shares of PrecigenSEC Form 416 May 2025Common Stock · traded 16 May 2025 · filed 16 May 2025
- was granted 1,079,137 shares of Precigen (a derivative holding)SEC Form 418 April 2025Restricted Stock Units · traded 17 April 2025 · filed 18 April 2025
- was granted 825,000 shares of PrecigenSEC Form 43 February 2025Common Stock · traded 29 January 2025 · filed 3 February 2025
- had shares withheld for tax on 286,967 shares of PrecigenSEC Form 43 February 2025Common Stock · traded 29 January 2025 · filed 3 February 2025
- was granted 1,803,000 shares of Precigen (a derivative holding)SEC Form 431 May 2024Option to Purchase Common Stock (Right to Buy) · traded 31 May 2024 · filed 31 May 2024
- was granted 1,071,429 shares of Precigen (a derivative holding)SEC Form 49 April 2024Restricted Stock Units · traded 5 April 2024 · filed 9 April 2024
- exercised options over 1,071,429 shares of Precigen (a derivative holding)SEC Form 49 April 2024Restricted Stock Units · traded 5 April 2024 · filed 9 April 2024
- exercised options over 1,071,429 shares of PrecigenSEC Form 49 April 2024Common Stock · traded 5 April 2024 · filed 9 April 2024
- had shares withheld for tax on 410,357 shares of PrecigenSEC Form 49 April 2024Common Stock · traded 5 April 2024 · filed 9 April 2024
- returned to the issuer 40,501 shares of Kinnate Biopharma (a derivative holding)SEC Form 45 April 2024Stock Option (right to buy) · traded 3 April 2024 · filed 5 April 2024
- returned to the issuer 25,000 shares of Kinnate Biopharma (a derivative holding)SEC Form 45 April 2024Stock Option (right to buy) · traded 3 April 2024 · filed 5 April 2024
- returned to the issuer 20,250 shares of Kinnate Biopharma (a derivative holding)SEC Form 45 April 2024Stock Option (right to buy) · traded 3 April 2024 · filed 5 April 2024
- exercised options over 141,587 shares of Precigen (a derivative holding)SEC Form 425 August 2023Restricted Stock Units · traded 23 August 2023 · filed 25 August 2023
- exercised options over 141,587 shares of PrecigenSEC Form 425 August 2023Common Stock · traded 23 August 2023 · filed 25 August 2023
- ▼ sold on the open market 76,969 shares of PrecigenSEC Form 425 August 2023Common Stock · traded 25 August 2023 · filed 25 August 2023
- exercised options over 141,587 shares of Precigen (a derivative holding)SEC Form 418 August 2023Restricted Stock Units · traded 16 August 2023 · filed 18 August 2023
- exercised options over 141,587 shares of PrecigenSEC Form 418 August 2023Common Stock · traded 16 August 2023 · filed 18 August 2023
- ▼ sold on the open market 55,855 shares of PrecigenSEC Form 418 August 2023Common Stock · traded 18 August 2023 · filed 18 August 2023
- exercised options over 141,587 shares of Precigen (a derivative holding)SEC Form 411 August 2023Restricted Stock Units · traded 9 August 2023 · filed 11 August 2023
- exercised options over 141,587 shares of PrecigenSEC Form 411 August 2023Common Stock · traded 9 August 2023 · filed 11 August 2023
- ▼ sold on the open market 41,436 shares of PrecigenSEC Form 411 August 2023Common Stock · traded 11 August 2023 · filed 11 August 2023
- exercised options over 141,587 shares of Precigen (a derivative holding)SEC Form 44 August 2023Restricted Stock Units · traded 2 August 2023 · filed 4 August 2023
- exercised options over 141,587 shares of PrecigenSEC Form 44 August 2023Common Stock · traded 2 August 2023 · filed 4 August 2023
- ▼ sold on the open market 52,870 shares of PrecigenSEC Form 44 August 2023Common Stock · traded 4 August 2023 · filed 4 August 2023
- was granted 25,000 shares of Kinnate Biopharma (a derivative holding)SEC Form 413 June 2023Stock Option (right to buy) · traded 12 June 2023 · filed 13 June 2023
- was granted 1,732,300 shares of Precigen (a derivative holding)SEC Form 42 May 2023Option to Purchase Common Stock (Right to Buy) · traded 28 April 2023 · filed 2 May 2023
- was granted 849,520 shares of Precigen (a derivative holding)SEC Form 428 March 2023Restricted Stock Units · traded 24 March 2023 · filed 28 March 2023
- exercised options over 283,173 shares of Precigen (a derivative holding)SEC Form 428 March 2023Restricted Stock Units · traded 24 March 2023 · filed 28 March 2023
- was granted 369,596 shares of Precigen (a derivative holding)SEC Form 428 March 2023Option to Purchase Common Stock (Right to Buy) · traded 24 March 2023 · filed 28 March 2023
- exercised options over 283,173 shares of PrecigenSEC Form 428 March 2023Common Stock · traded 24 March 2023 · filed 28 March 2023
- ▲ bought on the open market 22,857 shares of PrecigenSEC Form 430 January 2023Common Stock · traded 27 January 2023 · filed 30 January 2023
- exercised options over 17,665 shares of Precigen (a derivative holding)SEC Form 46 January 2023Restricted Stock Units · traded 4 January 2023 · filed 6 January 2023
- exercised options over 17,665 shares of PrecigenSEC Form 46 January 2023Common Stock · traded 4 January 2023 · filed 6 January 2023
- was granted 20,250 shares of Kinnate Biopharma (a derivative holding)SEC Form 415 June 2022Stock Option (right to buy) · traded 13 June 2022 · filed 15 June 2022
- exercised options over 340,909 shares of Precigen (a derivative holding)SEC Form 416 May 2022Restricted Stock Units · traded 12 May 2022 · filed 16 May 2022
- exercised options over 340,909 shares of PrecigenSEC Form 416 May 2022Common Stock · traded 12 May 2022 · filed 16 May 2022
- ▼ sold on the open market 177,968 shares of PrecigenSEC Form 416 May 2022Common Stock · traded 13 May 2022 · filed 16 May 2022
- was granted 340,909 shares of Precigen (a derivative holding)SEC Form 422 March 2022Restricted Stock Units · traded 18 March 2022 · filed 22 March 2022
- was granted 847,000 shares of Precigen (a derivative holding)SEC Form 44 February 2022Option to Purchase Common Stock (Right to Buy) · traded 2 February 2022 · filed 4 February 2022
- exercised options over 17,667 shares of Precigen (a derivative holding)SEC Form 46 January 2022Restricted Stock Units · traded 4 January 2022 · filed 6 January 2022
- exercised options over 17,667 shares of PrecigenSEC Form 46 January 2022Common Stock · traded 4 January 2022 · filed 6 January 2022
- ▼ sold on the open market 1,357 shares of PrecigenSEC Form 46 January 2022Common Stock · traded 5 January 2022 · filed 6 January 2022
- ▼ sold on the open market 5,603 shares of PrecigenSEC Form 46 January 2022Common Stock · traded 5 January 2022 · filed 6 January 2022
- exercised options over 9,765 shares of Precigen (a derivative holding)SEC Form 44 January 2022Restricted Stock Units · traded 2 January 2022 · filed 4 January 2022
- exercised options over 9,765 shares of PrecigenSEC Form 44 January 2022Common Stock · traded 2 January 2022 · filed 4 January 2022
- ▼ sold on the open market 3,848 shares of PrecigenSEC Form 44 January 2022Common Stock · traded 3 January 2022 · filed 4 January 2022
- exercised options over 25,000 shares of Precigen (a derivative holding)SEC Form 420 July 2021Restricted Stock Units · traded 17 July 2021 · filed 20 July 2021
- exercised options over 25,000 shares of PrecigenSEC Form 420 July 2021Common Stock · traded 17 July 2021 · filed 20 July 2021
- ▼ sold on the open market 12,531 shares of PrecigenSEC Form 420 July 2021Common Stock · traded 19 July 2021 · filed 20 July 2021
- was granted 40,501 shares of Kinnate Biopharma (a derivative holding)SEC Form 428 June 2021Stock Option (right to buy) · traded 24 June 2021 · filed 28 June 2021
- exercised options over 97,276 shares of Precigen (a derivative holding)SEC Form 414 May 2021Restricted Stock Units · traded 12 May 2021 · filed 14 May 2021
- exercised options over 97,276 shares of PrecigenSEC Form 414 May 2021Common Stock · traded 12 May 2021 · filed 14 May 2021
- ▼ sold on the open market 47,433 shares of PrecigenSEC Form 414 May 2021Common Stock · traded 13 May 2021 · filed 14 May 2021
- was granted 97,276 shares of Precigen (a derivative holding)SEC Form 429 March 2021Restricted Stock Units · traded 25 March 2021 · filed 29 March 2021
- exercised options over 500,000 shares of PrecigenSEC Form 47 January 2021Common Stock · traded 5 January 2021 · filed 7 January 2021
- ▼ sold on the open market 260,045 shares of PrecigenSEC Form 47 January 2021Common Stock · traded 6 January 2021 · filed 7 January 2021
- exercised options over 500,000 shares of Precigen (a derivative holding)SEC Form 47 January 2021Restricted Stock Units · traded 5 January 2021 · filed 7 January 2021
- exercised options over 17,667 shares of PrecigenSEC Form 46 January 2021Common Stock · traded 4 January 2021 · filed 6 January 2021
- ▼ sold on the open market 9,040 shares of PrecigenSEC Form 46 January 2021Common Stock · traded 5 January 2021 · filed 6 January 2021
- exercised options over 17,667 shares of Precigen (a derivative holding)SEC Form 46 January 2021Restricted Stock Units · traded 4 January 2021 · filed 6 January 2021
- exercised options over 9,766 shares of PrecigenSEC Form 45 January 2021Common Stock · traded 2 January 2021 · filed 5 January 2021
- ▼ sold on the open market 5,279 shares of PrecigenSEC Form 45 January 2021Common Stock · traded 4 January 2021 · filed 5 January 2021
- exercised options over 9,766 shares of Precigen (a derivative holding)SEC Form 45 January 2021Restricted Stock Units · traded 2 January 2021 · filed 5 January 2021
- exercised options over 25,000 shares of Precigen (a derivative holding)SEC Form 421 July 2020Restricted Stock Units · traded 17 July 2020 · filed 21 July 2020
- exercised options over 25,000 shares of PrecigenSEC Form 421 July 2020Common Stock · traded 17 July 2020 · filed 21 July 2020
- ▼ sold on the open market 12,220 shares of PrecigenSEC Form 421 July 2020Common Stock · traded 20 July 2020 · filed 21 July 2020
- exercised options over 500,000 shares of Precigen (a derivative holding)SEC Form 418 May 2020Restricted Stock Units · traded 14 May 2020 · filed 18 May 2020
- exercised options over 500,000 shares of PrecigenSEC Form 418 May 2020Common Stock · traded 14 May 2020 · filed 18 May 2020
- ▼ sold on the open market 217,527 shares of PrecigenSEC Form 418 May 2020Common Stock · traded 15 May 2020 · filed 18 May 2020
- exercised options over 14,340 shares of Precigen (a derivative holding)SEC Form 42 April 2020Restricted Stock Units · traded 31 March 2020 · filed 2 April 2020
- exercised options over 14,340 shares of PrecigenSEC Form 42 April 2020Common Stock · traded 31 March 2020 · filed 2 April 2020
- ▼ sold on the open market 5,450 shares of PrecigenSEC Form 42 April 2020Common Stock · traded 1 April 2020 · filed 2 April 2020
- was granted 500,000 shares of Precigen (a derivative holding)SEC Form 423 March 2020Restricted Stock Units · traded 23 March 2020 · filed 23 March 2020
- exercised options over 17,667 shares of Intrexon (a derivative holding)SEC Form 47 January 2020Restricted Stock Units · traded 4 January 2020 · filed 7 January 2020
- was granted 500,000 shares of Intrexon (a derivative holding)SEC Form 47 January 2020Restricted Stock Units · traded 5 January 2020 · filed 7 January 2020
- was granted 1,500,000 shares of Intrexon (a derivative holding)SEC Form 47 January 2020Option to Purchase Common Stock (Right to Buy) · traded 5 January 2020 · filed 7 January 2020
- was granted 1,500,000 shares of Intrexon (a derivative holding)SEC Form 47 January 2020Option to Purchase Common Stock (Right to Buy) · traded 5 January 2020 · filed 7 January 2020
- was granted 1,500,000 shares of Intrexon (a derivative holding)SEC Form 47 January 2020Option to Purchase Common Stock (Right to Buy) · traded 5 January 2020 · filed 7 January 2020
- exercised options over 17,667 shares of IntrexonSEC Form 47 January 2020Common Stock · traded 4 January 2020 · filed 7 January 2020
- ▼ sold on the open market 6,732 shares of IntrexonSEC Form 47 January 2020Common Stock · traded 6 January 2020 · filed 7 January 2020
- exercised options over 9,766 shares of Intrexon (a derivative holding)SEC Form 46 January 2020Restricted Stock Units · traded 2 January 2020 · filed 6 January 2020
- exercised options over 9,766 shares of IntrexonSEC Form 46 January 2020Common Stock · traded 2 January 2020 · filed 6 January 2020
- ▼ sold on the open market 3,886 shares of IntrexonSEC Form 46 January 2020Common Stock · traded 3 January 2020 · filed 6 January 2020
- exercised options over 14,340 shares of Intrexon (a derivative holding)SEC Form 43 January 2020Restricted Stock Units · traded 31 December 2019 · filed 3 January 2020
- exercised options over 14,340 shares of IntrexonSEC Form 43 January 2020Common Stock · traded 31 December 2019 · filed 3 January 2020
- ▼ sold on the open market 4,830 shares of IntrexonSEC Form 43 January 2020Common Stock · traded 2 January 2020 · filed 3 January 2020
- exercised options over 14,341 shares of Intrexon (a derivative holding)SEC Form 42 October 2019Restricted Stock Units · traded 30 September 2019 · filed 2 October 2019
- exercised options over 14,341 shares of IntrexonSEC Form 42 October 2019Common Stock · traded 30 September 2019 · filed 2 October 2019
- ▼ sold on the open market 5,005 shares of IntrexonSEC Form 42 October 2019Common Stock · traded 1 October 2019 · filed 2 October 2019
- exercised options over 25,000 shares of Intrexon (a derivative holding)SEC Form 419 July 2019Restricted Stock Units · traded 17 July 2019 · filed 19 July 2019
- exercised options over 25,000 shares of IntrexonSEC Form 419 July 2019Common Stock · traded 17 July 2019 · filed 19 July 2019
- ▼ sold on the open market 8,484 shares of IntrexonSEC Form 419 July 2019Common Stock · traded 18 July 2019 · filed 19 July 2019
- exercised options over 14,341 shares of Intrexon (a derivative holding)SEC Form 42 July 2019Restricted Stock Units · traded 30 June 2019 · filed 2 July 2019
- exercised options over 14,341 shares of IntrexonSEC Form 42 July 2019Common Stock · traded 30 June 2019 · filed 2 July 2019
- ▼ sold on the open market 4,822 shares of IntrexonSEC Form 42 July 2019Common Stock · traded 1 July 2019 · filed 2 July 2019
- was granted 57,362 shares of Intrexon (a derivative holding)SEC Form 411 April 2019Restricted Stock Units · traded 9 April 2019 · filed 11 April 2019
- was granted 56,891 shares of Intrexon (a derivative holding)SEC Form 429 January 2019Restricted Stock Units · traded 25 January 2019 · filed 29 January 2019
- was granted 13,775 shares of Intrexon (a derivative holding)SEC Form 48 January 2019Restricted Stock Units · traded 4 January 2019 · filed 8 January 2019
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.